期刊文献+

血管活性药物对感染性休克患者肾脏灌注的影响

Effect of Vasoactive Drugs on Renal Perfusion in Patients With Septic Shock
下载PDF
导出
摘要 目的:观察血管活性药物多巴胺、多巴胺加间羟胺、去氧肾上腺素加多巴酚丁胺对感染性休克患者肾脏灌注的影响。方法:63例感染性休克患者经过积极的液体复苏以后,随机分成3组,分别应用多巴胺、多巴胺加间羟胺、去氧肾上腺素加多巴酚丁胺,观察尿量、肌酐清除率(Ccr)、钠排泄分数(FeNa)的变化。结果:多巴胺组和去氧肾上腺素加多巴酚丁胺组尿量明显多于基础值时(P<0.05);Ccr去氧肾上腺素加多巴酚丁胺组明显高于基础值时和其他各组(P<0.05);FeNa去氧肾上腺素加多巴酚丁胺组明显低于基础值时和其他各组(P<0.05),多巴胺组与基础值时比较,显著增高(P<0.05)。结论:使用去氧肾上腺素加多巴酚丁胺能改善肾脏灌注,显著增加Ccr;多巴胺能增加尿量和FeNa,但改善肾脏灌注作用不确切;多巴胺加间羟胺不能改善肾灌注。 Objective: To observe the effect of vaso-active drugs (dopamine, dopamine plus metaraminol, phenylephrine plus dobutamine) on renal perfusion in patients with septic shock. Methods: Sixty-three patients with septic shock after volume resuscitation were divided randomly into three groups. Changes of urine output, creatinine clearance (Ccr) and fractional excretion of sodium (FeNa) were observed. Results: Urine output in both dopamine group and phenylephrine plus dobutamine group were much more increased than baseline value(P〈0. 05) ; Ccr in phenylephrine plus dohutamine group was significantly higher than that in baseline group and other groups(P〈 0. 05) ; FeNa in phenylephrine plus dobutamine group was obviously lower than that in baseline and other groups(P 〈0. 05) ; but FeNa in dopamine group was much higher than baseline (P〈0. 05). Conclusions: Treatment with phenylephrine plus dobutamine could significantly improve renal perfusion and increase Ccr. Dopamine could markedly elevate urine output and FeNa, but the role of improving renal perfusion was not definit. Dopamine plus metaraminol can not improve renal perfusion.
出处 《内科急危重症杂志》 2007年第4期130-132,共3页 Journal of Critical Care In Internal Medicine
关键词 血管活性药物 感染性休克 肾脏灌注 肾功能 Vaso-activated drug Sepsis shock Renal perfusion Renal function
  • 相关文献

参考文献7

  • 1Knaus WA,Draper EA,Wagner DP,et al.APACHEⅡ:a severity of disease classification system.Crit Care Med,1985,13:818.
  • 2American college of chest physicians / society of critical care medicine consensus conference:definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.Crit Care Med,1992,20:864.
  • 3Seri I,Kone BC,Gullans SR,et al.Locally formed dopamine inhibit Na+ -K+ -ATPase activity in rat renal cortical cells.Am J Physiol,2004,255:F666.
  • 4Ichai C,Paseron C,Carles M,et al.Prolonged dose dopamine infusion induces a transient improvement in renal function in hemodynamically stable,critically ill patients:a single blind,prospective,controlled study.Crit Care Med,2000,28:1329.
  • 5Lherm T,Troche G,Rossignol M,et al.Renal effects of dose dopamine in patients with sepsis syndrome or septic shock treated with catecholamines.Intensive Care Med,2003,22:213.
  • 6Martin C,Viviand X,Leone M,et al.Effect of phenylephrine on the outcome of septic shock.Crit Care Med,2001,28:2758.
  • 7Girbes A R J,Hoogenberg K.The use of dopamine and phenylephrine in the ICU.In:Yearbook of intensive care and emergency medicine.Vincent J L,Berlin:Springer Verlag,2002,178.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部